Artificial Intelligence

Echo AI Improves LVEF Workflow and Variability

Cedars-Sinai researchers published what might be the strongest evidence yet of AI’s ability to improve echocardiography workflows and accuracy.

The researchers randomized 3,495 transthoracic echo LVEF studies to be assessed by either a Cedars-Sinai-developed AI tool or expert sonographers (within the standard cardiology PACS workflow), before final assessments by blinded cardiologists.

This was the first blinded RCT evaluating an echo AI solution, and one of the first for any imaging AI solutions.

Echo AI nailed the study’s primary endpoint, as the final cardiologist assessments required substantial LVEF changes (>5% change) far less often with AI-based studies than those from the sonographer group (16.8% vs. 27.2%).

The echo AI solution AI further supported its advantage over sonographer assessments, producing…

  • A smaller average LVEF difference between the initial and final cardiologist assessments (2.79% vs. 3.77%)
  • A smaller average LVEF difference between the final cardiologist assessments and patients’ previous/historical cardiologist assessments (6.29% vs. 7.23%)
  • Faster average initial LVEF assessments (AI 131 seconds faster)
  • Faster median cardiologist LVEF assessments (54 vs. 64 seconds)

The blinded cardiologists also often couldn’t tell whether AI or the human sonographers produced the initial assessments (43%), while predicting the correct assessment source only slightly more often than the incorrect source (32% & 24%).

The Takeaway

This study shows that AI-based LVEF assessments can be “non-inferior and even superior” to initial assessment by sonographers, while also reducing labor and variability throughout the echo workflow. 

Even though previous echo AI research has produced similar results and this study only used data from a single center, the fact that it was echo AI’s first blinded RCT is very notable, and bolsters the growing body of evidence supporting AI’s ability to improve echo workflows in the real world.

Get twice-weekly insights on the biggest stories shaping cardiology.

You might also like

Electrophysiology August 21, 2025

Conduction-System Pacing Succeeds at Treating AV Block August 21, 2025

Conduction-system pacing could be poised to reshape standard care for atrioventricular (AV) block patients after the randomized CSPACE trial demonstrated its significant benefits over traditional right ventricular septal pacing. Taking a closer look at CSP’s potential, the CSPACE trial enrolled 202 patients with AV block at two Australian hospitals, randomizing them to conduction-system pacing or […]

Cardiology Pharmaceuticals August 18, 2025

Rivaroxaban Monotherapy Could Be Better for CAD + AFib August 18, 2025

New analysis from the AFIRE trial suggests rivaroxaban monotherapy might be emerging as a preferred antithrombotic strategy for patients with AFib and stable coronary artery disease, especially in older age groups. The Post Hoc AFIRE Analysis examined 2,215 Japanese patients with AFib and stable CAD, stratifying them into four age groups (<70, 70-74, 75-79, and […]

Surgeries & Interventions August 14, 2025

TEER Could Save Lives in AFMR Patients August 14, 2025

Shedding light on a new treatment for an understudied condition, data published in EHJ suggests that transcatheter edge-to-edge repair (TEER) delivers significant survival advantages in patients with atrial functional mitral regurgitation (FMR). The new OCEAN-Mitral/REVEAL-AFMR Analysis compared 441 TEER-treated patients against 640 medically managed controls with moderate or severe atrial FMR, stating a solid case […]

You might also like..

Select All

You're signed up!

It's great to have you as a reader. Check your inbox for a welcome email.

-- The Cardiac Wire Team

You're all set!